Elevance Health (ELV) Short-term Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Short-term Investments data on file, last reported at $25.9 billion in Q1 2026.

• Quarterly Short-term Investments rose 3523.08% year-over-year to $25.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.9 billion (up 3523.08% YoY) and the FY2025 annual result came in at $740.0 million, down 97.06% from the prior year.
• Short-term Investments advanced to $25.9 billion in Q1 2026 per ELV's latest filing, from $740.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $29.6 billion in Q4 2023 and bottomed at $165.0 million in Q3 2023.
• The 5-year median for Short-term Investments is $1.5 billion (2022), against an average of $11.3 billion.
• The widest annual swing landed in 2023, when Short-term Investments plunged 98.94%; it then surged 4158.92% in 2025.
• Tracing ELV's Short-term Investments over 5 years: stood at $26.0 billion in 2022, then climbed by 14.11% to $29.6 billion in 2023, then decreased by 14.9% to $25.2 billion in 2024, then tumbled by 97.06% to $740.0 million in 2025, then soared by 3400.68% to $25.9 billion in 2026.
• Per Business Quant, the three latest ELV Short-term Investments figures stand at $25.9 billion (Q1 2026), $740.0 million (Q4 2025), and $26.3 billion (Q3 2025).

Peer Comparison